Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 975.79 1.99 (0.2%) Market Cap: 107.52 Bil Enterprise Value: 99.35 Bil PE Ratio: 28.83 PB Ratio: 3.98 GF Score: 94/100

Regeneron Pharmaceuticals Inc at Leerink Global Healthcare Conference Transcript

Feb 25, 2020 / 03:00PM GMT
Release Date Price: $442.35 (+3.99%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst

Is this on? No? Oh, there it goes. Now we're on. So thanks, everybody, for joining us. I'm Geoff Porges, Director of Therapeutics Research, and I'm delighted to welcome Regeneron to our Global Healthcare Conference. Regeneron is represented by Marion McCourt, who's Senior Vice President and Head of Commercial at Regeneron. Thanks, Marion, for coming; and Justin Holko to her right, who's Vice President of Investor Relations. And other members of the IR team are also here. So thanks again for coming.

Questions & Answers

Geoffrey Craig Porges;Marion E. McCourt
SVB Leerink LLC, Research Division - Director of Therapeutics Research, MD & Senior Biotechnology Analyst;Regeneron Pharmaceuticals, Inc. - Senior VP & Head of Commercial

Wow, lots to talk about, Marion. What's going on with Beovu? What happened over the weekend? It was like the weekend that just keeps on giving, isn't it?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot